Jiang B - Search Results

1

DNA content and its relationship with pathology and prognosis of colorectal carcinoma.

Jiang B, Liu CG, Wang MW, Zhao DH, Li Y, Ji XL. Jiang B, et al. Chin Med J (Engl). 1992 Mar;105(3):241-6. Chin Med J (Engl). 1992. PMID: 1395845

2

The effect of bu shen sheng xue fang on beta-thalassemia at gene level.

Wu Z, Jiang B, Cui J, Ji X, Huang X, Cai H, Chen P, Wang R, Huang Y. Wu Z, et al. Among authors: jiang b. J Tradit Chin Med. 1998 Dec;18(4):300-3. J Tradit Chin Med. 1998. PMID: 10453601

3

Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going?

Wang Y, Wang H, Zhou L, Lu J, Jiang B, Liu C, Guo J. Wang Y, et al. Among authors: jiang b. Photodiagnosis Photodyn Ther. 2020 Sep;31:101876. doi: 10.1016/j.pdpdt.2020.101876. Epub 2020 Jun 10. Photodiagnosis Photodyn Ther. 2020. PMID: 32534246 Review.

4

USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target.

Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J. Wang Y, et al. Among authors: jiang b. Cancer Cell Int. 2020 Jul 10;20:298. doi: 10.1186/s12935-020-01391-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32669974 Free PMC article. Review.

5

Clinicopathological and prognostic significance of ubiquitin-specific peptidase 15 and its relationship with transforming growth factor-β receptors in patients with pancreatic ductal adenocarcinoma.

Jiang B, Zhou L, Lu J, Wang Y, Liu C, Liang Z, Zhou W, You L, Guo J. Jiang B, et al. J Gastroenterol Hepatol. 2021 Feb;36(2):507-515. doi: 10.1111/jgh.15244. Epub 2020 Sep 9. J Gastroenterol Hepatol. 2021. PMID: 32875609

6

Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer.

Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Wang Y, et al. Among authors: jiang b. Cancer Cell Int. 2020 Sep 15;20:457. doi: 10.1186/s12935-020-01550-y. eCollection 2020. Cancer Cell Int. 2020. PMID: 32973402 Free PMC article. Review.

7

Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer.

Wang Y, Zhou L, Lu J, Jiang B, Liu C, Liang Z, Zhou W, Guo J. Wang Y, et al. Among authors: jiang b. Exp Cell Res. 2020 Nov 15;396(2):112317. doi: 10.1016/j.yexcr.2020.112317. Epub 2020 Oct 8. Exp Cell Res. 2020. PMID: 33038351

8

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review.

Wang Y, Zhong X, Zhou L, Lu J, Jiang B, Liu C, Guo J. Wang Y, et al. Among authors: jiang b. Front Oncol. 2020 Sep 17;10:1466. doi: 10.3389/fonc.2020.01466. eCollection 2020. Front Oncol. 2020. PMID: 33042793 Free PMC article.

9

Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?

Jiang B, Zhou L, Lu J, Wang Y, Liu C, You L, Guo J. Jiang B, et al. Front Oncol. 2020 Oct 15;10:576399. doi: 10.3389/fonc.2020.576399. eCollection 2020. Front Oncol. 2020. PMID: 33178608 Free PMC article. Review.

10

Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer.

Jiang B, Zhou L, Lu J, Wang Y, Liu C, Zhou W, Guo J. Jiang B, et al. Scand J Gastroenterol. 2021 Jan;56(1):59-67. doi: 10.1080/00365521.2020.1853806. Epub 2020 Dec 7. Scand J Gastroenterol. 2021. PMID: 33284659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,928 results

Search Page

Filters